ETX
LSE

e-therapeutics plc

Overview
ETX
Symbol
LSE
Exchange
About stock

e-Therapeutics plc engages in drug discovery research activities in the United Kingdom. Its computational platform provides in silico screens generate predictions on compounds and/or targets that can have a significant perturbative effect on the biology of interest, captured by its network models, as well as developing RNAi platform for highly specific gene silencing. The company was incorporated in 2001 and is based in London, the United Kingdom.

Address: 4 Kingdom Street, London, United Kingdom, W2 6BD

e-therapeutics plc dividend calculator
Report issue